Clinical Trial Update: MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for MultiStem administration in ischemic stroke to improve recovery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• MultiStem (mesenchymal-like stem cell product)

Snippet

Sponsor: Healios K.K. | Conditions: Ischemic Stroke | Phase 3 | Status: UNKNOWN